TP53 and neoplasm: Functional studies have revealed that TP53 truncating mutants located on exon‐6/exon‐7 can translocate to the mitochondria and enhance tumor characteristics by interacting with the mitochondria inner pore permeability regulator, Cyclophilin D (CypD).